The release of NextGen DMS 4 will enable automated donor address verification, paperless intake and annual medical assessment and will extend capabilities of the donor floor mobile application to streamline phlebotomy documentation. Additionally, new quality checklists used by staff at key processing steps will help collection centers quickly and reliably follow their standard operating procedures.
"NextGen DMS 4 is an important achievement on our path to the plasma center of the future; a future that will deliver significant efficiency gains in the collection process, resulting in tangible value to our customers," said Tom McCurdy, President, Global Plasma. "Our solutions are used in plasma collections worldwide to help deliver quality, life-changing therapies. We are proud of our mission and excited about this release for our customers," he said.
Haemonetics (NYSE: HAE) is a global healthcare company dedicated to providing a suite of innovative hematology products and solutions for our customers, to help them improve patient care and reduce the cost of healthcare. Our technology addresses important medical markets: blood and plasma component collection, the surgical suite, and hospital transfusion services. To learn more about Haemonetics, please visit http://www.haemonetics.com/
Gerry Gould, VP, Investor Relations
Sandra Jesse, EVP, Chief Legal Officer
Logo - http://photos.prnewswire.com/prnh/20160405/351568LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/haemonetics-announces-the-release-of-nextgen-dms-4-300374717.html
SOURCE Haemonetics Corporation